3 Healthcare Stocks Popping Post Earnings

Merck & Co Inc. (NYSE:MRK) reported its results for the first quarter. Net income for Merck & Co Inc. rose to $1.74 billion (56 cents per share) vs. $1.04 billion (34 cents per share) in the same quarter a year earlier. This marks a rise of 66.6% from the year-earlier quarter. Revenue rose 1.3% to $11.73 billion from the year-earlier quarter. Merck & Co Inc. reported adjusted net income of 99 cents per share. By that measure, the company beat the mean estimate of 98 cents per share. Analysts were expecting revenue of $11.82 billion.

Covidien plc (NYSE:COV) reported its results for the second quarter. Net income for Covidien plc rose to $497 million ($1.01 per share) vs. $455 million (92 cents per share) in the same quarter a year earlier. This marks a rise of 9.2% from the year-earlier quarter. Covidien plc reported adjusted net income of $1.05 per share. By that measure, the company beat the mean estimate of $1.03 per share.

Coventry Health Care Inc. (NYSE:CVH) reported higher profit for the first quarter as revenue showed growth. Net income for Coventry Health Care Inc. rose to $170.7 million ($1.20 per share) vs. $110.2 million (73 cents per share) in the same quarter a year earlier. This marks a rise of 54.9% from the year-earlier quarter. Revenue rose 21.1% to $3.69 billion from the year-earlier quarter. Coventry Health Care Inc. reported adjusted net income of 62 cents per share. By that measure, the company fell short of mean estimate of 63 cents per share. It beat the average revenue estimate of $3.49 billion.